81 related articles for article (PubMed ID: 12068307)
1. Nuclear exclusion of Smad2 is a mechanism leading to loss of competence.
Grimm OH; Gurdon JB
Nat Cell Biol; 2002 Jul; 4(7):519-22. PubMed ID: 12068307
[TBL] [Abstract][Full Text] [Related]
2. Notch signaling modulates the nuclear localization of carboxy-terminal-phosphorylated smad2 and controls the competence of ectodermal cells for activin A.
Abe T; Furue M; Kondow A; Matsuzaki K; Asashima M
Mech Dev; 2005 May; 122(5):671-80. PubMed ID: 15817224
[TBL] [Abstract][Full Text] [Related]
3. Smad2 role in mesoderm formation, left-right patterning and craniofacial development.
Nomura M; Li E
Nature; 1998 Jun; 393(6687):786-90. PubMed ID: 9655392
[TBL] [Abstract][Full Text] [Related]
4. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Smad nucleocytoplasmic shuttling in living cells.
Nicolás FJ; De Bosscher K; Schmierer B; Hill CS
J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432
[TBL] [Abstract][Full Text] [Related]
7. SMAD proteins and mammalian anatomy.
Derynck R
Nature; 1998 Jun; 393(6687):737-9. PubMed ID: 9655387
[No Abstract] [Full Text] [Related]
8. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
9. Neural induction requires continued suppression of both Smad1 and Smad2 signals during gastrulation.
Chang C; Harland RM
Development; 2007 Nov; 134(21):3861-72. PubMed ID: 17933792
[TBL] [Abstract][Full Text] [Related]
10. Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-beta ligands.
Batut J; Howell M; Hill CS
Dev Cell; 2007 Feb; 12(2):261-74. PubMed ID: 17276343
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Smad2 in Tgf-beta3-null mutant mice rescues cleft palate.
Cui XM; Shiomi N; Chen J; Saito T; Yamamoto T; Ito Y; Bringas P; Chai Y; Shuler CF
Dev Biol; 2005 Feb; 278(1):193-202. PubMed ID: 15649471
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
13. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads.
Schmierer B; Hill CS
Mol Cell Biol; 2005 Nov; 25(22):9845-58. PubMed ID: 16260601
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
16. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
Lau MT; Ge W
Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
[TBL] [Abstract][Full Text] [Related]
17. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
[TBL] [Abstract][Full Text] [Related]
18. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
19. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
20. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
